Hisamitsu Pharmaceutical Co. Ltd.

10/28/2022 | Press release | Distributed by Public on 10/28/2022 00:06

Notification of the Results of the Phase III Clinical Study of HP-5000 for Osteoarthritis Pain of the Knee in the U.S. (Pain Relief and Anti-Inflammatory Patch)